Medlive Technology Co., Ltd.

SEHK:2192 株式レポート

時価総額：HK$6.6b

Medlive Technology バランスシートの健全性

財務の健全性 基準チェック /66

Medlive Technologyの総株主資本はCN¥4.7B 、総負債はCN¥0.0で、負債比率は0%となります。総資産と総負債はそれぞれCN¥4.9BとCN¥214.0Mです。 Medlive Technologyの EBIT はCN¥99.3Mで、利息カバレッジ比率-0.5です。現金および短期投資はCN¥3.9Bです。

主要情報

0%

負債資本比率

CN¥0

負債

インタレスト・カバレッジ・レシオ-0.5x
現金CN¥3.86b
エクイティCN¥4.73b
負債合計CN¥214.01m
総資産CN¥4.94b

財務の健全性に関する最新情報

更新なし

Recent updates

Investors Shouldn't Be Too Comfortable With Medlive Technology's (HKG:2192) Earnings

Oct 02
Investors Shouldn't Be Too Comfortable With Medlive Technology's (HKG:2192) Earnings

Pinning Down Medlive Technology Co., Ltd.'s (HKG:2192) P/E Is Difficult Right Now

Sep 27
Pinning Down Medlive Technology Co., Ltd.'s (HKG:2192) P/E Is Difficult Right Now

Medlive Technology (HKG:2192) Could Be Struggling To Allocate Capital

Jul 04
Medlive Technology (HKG:2192) Could Be Struggling To Allocate Capital

Medlive Technology Co., Ltd.'s (HKG:2192) Business Is Yet to Catch Up With Its Share Price

Apr 08
Medlive Technology Co., Ltd.'s (HKG:2192) Business Is Yet to Catch Up With Its Share Price

Medlive Technology (HKG:2192) Is Reinvesting At Lower Rates Of Return

Feb 20
Medlive Technology (HKG:2192) Is Reinvesting At Lower Rates Of Return

Are Medlive Technology Co., Ltd. (HKG:2192) Investors Paying Above The Intrinsic Value?

Jan 10
Are Medlive Technology Co., Ltd. (HKG:2192) Investors Paying Above The Intrinsic Value?

Medlive Technology Co., Ltd.'s (HKG:2192) Intrinsic Value Is Potentially 20% Below Its Share Price

Sep 27
Medlive Technology Co., Ltd.'s (HKG:2192) Intrinsic Value Is Potentially 20% Below Its Share Price

Medlive Technology (HKG:2192) Is Reinvesting At Lower Rates Of Return

Jul 10
Medlive Technology (HKG:2192) Is Reinvesting At Lower Rates Of Return

Medlive Technology Co., Ltd. (HKG:2192) Shares Slammed 28% But Getting In Cheap Might Be Difficult Regardless

May 11
Medlive Technology Co., Ltd. (HKG:2192) Shares Slammed 28% But Getting In Cheap Might Be Difficult Regardless

Robust Earnings May Not Tell The Whole Story For Medlive Technology (HKG:2192)

May 02
Robust Earnings May Not Tell The Whole Story For Medlive Technology (HKG:2192)

Results: Medlive Technology Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Mar 26
Results: Medlive Technology Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Here's What's Concerning About Medlive Technology's (HKG:2192) Returns On Capital

Feb 06
Here's What's Concerning About Medlive Technology's (HKG:2192) Returns On Capital

There Are Reasons To Feel Uneasy About Medlive Technology's (HKG:2192) Returns On Capital

Oct 31
There Are Reasons To Feel Uneasy About Medlive Technology's (HKG:2192) Returns On Capital

Medlive Technology (HKG:2192) Could Be Struggling To Allocate Capital

Jul 14
Medlive Technology (HKG:2192) Could Be Struggling To Allocate Capital

These Analysts Just Made A Massive Downgrade To Their Medlive Technology Co., Ltd. (HKG:2192) EPS Forecasts

Apr 03
These Analysts Just Made A Massive Downgrade To Their Medlive Technology Co., Ltd. (HKG:2192) EPS Forecasts

Is Medlive Technology Co., Ltd. (HKG:2192) Worth HK$9.5 Based On Its Intrinsic Value?

Feb 22
Is Medlive Technology Co., Ltd. (HKG:2192) Worth HK$9.5 Based On Its Intrinsic Value?

財務状況分析

短期負債: 2192の 短期資産 ( CN¥4.0B ) が 短期負債 ( CN¥150.2M ) を超えています。

長期負債: 2192の短期資産 ( CN¥4.0B ) が 長期負債 ( CN¥63.8M ) を上回っています。

デット・ツー・エクイティの歴史と分析

負債レベル: 2192は負債がありません。

負債の削減: 2192 5 年前には負債がありませんでした。

債務返済能力: 2192には負債がないため、営業キャッシュフロー でカバーする必要はありません。

インタレストカバレッジ: 2192には負債がないため、利息支払い の負担は問題になりません。

貸借対照表

健全な企業の発掘

7D

1Y

7D

1Y

7D

1Y